Assessment of the biological and pharmacological effects of the a n b 3 and a n b 5 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors
暂无分享,去创建一个
S. Eckhardt | D. Gallemann | M. Morrow | L. Gore | C. O’Bryant | A. Baron | S. Hariharan | S. Holden | D. Colevas | M. Basche | D. Gustafson | D. Mcconkey | D. Davis | C. Zang